TRIFENS
associated with 0 other trademarks
pharmaceuticals, for use in the treatment of actinic keratosis, kaposi's sarcoma, basal cell carcinoma, cancers (all types, including leukemia and oth...

Words that describe this trademark:

basal cell carcinoma  carcinoma cancers  kaposis sarcoma  cancers types  actinic keratosis  cell carcinoma  treatment  keratosis  pharmaceuticals  sarcoma 

Serial Number:

75127998

Mark:

TRIFENS

Status:

Abandoned-No Statement of Use filed

Status Date:

11-07-1998

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

pharmaceuticals, for use in the treatment of actinic keratosis, kaposi's sarcoma, basal cell carcinoma, cancers (all types, including leukemia and other blood types), sickle cell anemia, restenosis, atherosclerosis, diabetic retinopathy, arteriosclerosis, diseases characterized by neovascularization, dermatologic condition, and gastro intestinal diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

02-11-1997

Mark Drawing Status:

Typed Drawing

Abandon Date:

11-07-1998

Business Name:

PENNIE & EDMONDS LLP

Correspondent Name:

Recent Trademark filings by this company